Understanding HTLV-I protease (Q35138127)

6 August 2017

1 reference

title

Understanding HTLV-I protease (English)

1 reference

Human T-lymphotropic virus 1

6 August 2017

0 references

author name string

Suzanne Beckham Shuker

1

1 reference

6 August 2017

Victoria L Mariani

2

1 reference

6 August 2017

Bryan E Herger

3

1 reference

6 August 2017

Kelly J Dennison

4

1 reference

6 August 2017

1 May 2003

1 reference

6 August 2017

Chemistry and Biology

1 reference

6 August 2017

10

1 reference

6 August 2017

373-380

1 reference

6 August 2017

5

1 reference

Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900104-2

7 January 2021

Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900104-2

7 January 2021

Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900104-2

7 January 2021

Guidelines for counseling human T-lymphotropic virus type I (HTLV-I)- and HTLV type II-infected persons

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900104-2

7 January 2021

Guarding against the most dangerous emerging pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900104-2

7 January 2021

Emerging infections: getting ahead of the curve

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900104-2

7 January 2021

A truncated HTLV-I envelope protein, lacking the hydrophobic membrane anchor domain, is associated with cellular membranes and virions

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900104-2

7 January 2021

In vitro infection of human macrophages by human T-cell leukemia/lymphotropic virus type I (HTLV-I)

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900104-2

7 January 2021

Complete nucleotide sequence of the AIDS virus, HTLV-III

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900104-2

7 January 2021

Retroviral protease-like sequence in the yeast transposon Ty 1

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900104-2

7 January 2021

Hydrophilic peptides derived from the transframe region of Gag-Pol inhibit the HIV-1 protease

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900104-2

7 January 2021

Identification of HTLV-I gag protease and its sequential processing of the gag gene product

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900104-2

7 January 2021

Purification and characterization of human T-cell leukemia virus type I protease produced in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900104-2

7 January 2021

Expression of human T-cell leukemia virus type I protease in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900104-2

7 January 2021

Human T-cell leukemia virus type 1 protease protein expressed in Escherichia coli possesses aspartic proteinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900104-2

7 January 2021

Analysis of substrate cleavage by recombinant protease of human T cell leukaemia virus type 1 reveals preferences and specificity of binding.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900104-2

7 January 2021

Requirement of N- and C-terminal regions for enzymatic activity of human T-cell leukemia virus type I protease

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900104-2

7 January 2021

Modelling, synthesis and biological activity of a BLV proteinase, made of (only) 116 amino acids

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900104-2

7 January 2021

A novel protease processing site in the transframe protein of human T-cell leukemia virus type 1 PR76(gag-pro) defines the N terminus of RT.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900104-2

7 January 2021

Identification of the RT-RH/IN cleavage site of HTLV-I.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900104-2

7 January 2021

Stabilization from autoproteolysis and kinetic characterization of the human T-cell leukemia virus type 1 proteinase

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900104-2

7 January 2021

Cloning of the bovine leukemia virus proteinase in Escherichia coli and comparison of its specificity to that of human T-cell leukemia virus proteinase

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900104-2

7 January 2021

Comparison of the substrate specificity of the human T-cell leukemia virus and human immunodeficiency virus proteinases

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900104-2

7 January 2021

HTLV-I protease cleavage of P19/24 substrates is not dependent on NaCl concentration

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900104-2

7 January 2021

Conformational stability and catalytic activity of HIV-1 protease are both enhanced at high salt concentration

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900104-2

7 January 2021

Proteolytic Processing of Particle-Associated Retroviral Polyproteins by Homologous and Heterologous Viral Proteinases

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900104-2

7 January 2021

Structural basis for specificity of retroviral proteases

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900104-2

7 January 2021

Substrates and inhibitors of human T-cell leukemia virus type I protease.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900104-2

7 January 2021

HIV type 1 protease inhibitors fail to inhibit HTLV-I Gag processing in infected cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900104-2

7 January 2021

Long-term maintenance combination chemotherapy with OPEC/MPEC (vincristine or methotrexate, prednisolone, etoposide and cyclophosphamide) or with daily oral etoposide and prednisolone can improve survival and quality of life in adult T-cell leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2803%2900104-2

7 January 2021

10.1016/S1074-5521(03)00104-2

Identifiers

DOI

1 reference

6 August 2017

1 reference